Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
The company's growth portfolio now nears 60% of total revenues, growing 16% YoY, effectively offsetting impending patent cliff losses. Key pipeline assets iberdomide and mezigdomide target relapsed/refractory multiple myeloma, with iberdomide's FDA decision expected by August 2026. Cobenfy, approved for schizophrenia, holds multi-indication potential with pivotal Alzheimer's Disease psychosis data expected at the end of 2026. Looking for a portfolio of ideas like this one? Members of Biotech Analysis Central get exclusive access to our subscriber-only portfolios. Learn More » VERODIBE/iStock via Getty Images The last time I wrote about Bristol-Myers Squibb BMY ), it was with a Seeking Alpha article entitled " Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion ." With respect to this More on my IG service This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace.
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- 3 Healthcare Stocks That Pay You While You Wait for the Growth [Yahoo! Finance]Yahoo! Finance
- 3 Healthcare Stocks That Pay You While You Wait for the Growth [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal [Yahoo! Finance]Yahoo! Finance
- AWS exec. expands on productivity benefits of training AI agents [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 4/17/26 - Form DEFA14A
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- BMY's page on the SEC website